Oxygen Therapy for Retinal Ischemia

Beth Israel Deaconess Medical Center

Overview

The investigators will be using nocturnal normobaric hyperoxia therapy in patients with diagnoses of conditions related to retinal ischemia.

Patients who receive a diagnosis of a condition relate to retinal ischemia and who pass the eligibility criteria will receive an oxygen concentrator to use at home. They will report back in follow up monthly for three to six months.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Conditions

Retinal Ischemia

Interventions

HyperoxiaDRUG

Patients will receive nocturnal normobaric hyperoxia therapy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of retinal-ischemia related condition Exclusion Criteria: * Complicating other ocular condition * History of smoking or lung conditions

Locations (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Outcomes

Primary Outcomes

Best Corrected Visual Acuity

Best Corrected Visual Acuity as measured by ETDRS chart

Time frame: 6 months

Macula Edema

Amount of ME present, as measured by OCT

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.